Anti-Snoring Device Market Size, Share & Industry Analysis, By Product Type (Nasal Devices, Oral Devices, Chin Straps, Position Control Device, Expiratory Positive Airway Pressure (EPAP) Device), By End-user (Hospital, Sleep Therapy Clinics, Homecare) And Regional Forecast, 2024-2032

Snoring is characterized as a vibration of the respiratory tract due to obstruction in the airway flow. Snoring is caused by various reasons such as obstruction of the airway, sleep apnea, sleep deprivation, obesity, and mouth breathing. A rising sedentary lifestyle has led to an increase in the prevalence of sleep deprivation, obesity, among others. Researchers from Oxford University have stated that insomnia is the most common sleep disorder, and in 2019 over 30% of adults suffered from the disorder. These factors are estimated to increase the adoption of anti-snoring devices among the population of the world. Snoring could be managed using various devices such as orthopedic pillows, nasal devices, oral appliances, etc.

The rising prevalence of sleep apnea among the elderly population worldwide is estimated to drive the market in the coming years. For instance, according to the Sleep Foundation, there are over 9% of adults in the U.S experienced obstructive sleep apnea in 2019. However, the Foundation states that many cases go undiagnosed. Increasing awareness regarding sleep disorders in developing counties is estimated to bolster the adoption of anti-snoring devices worldwide.

However, there is limited awareness regarding the serious side effects and reasons for snoring in developing nations such as India and Brazil. This factor could significantly restrain the growth of anti-snoring devices in the coming years.

Market Segmentation:

Globally, the anti-snoring device market can be categorized into product type, distribution channel, and region. Based on product type, the market can be segmented into nasal devices, oral devices, position control devices, expiratory positive airway pressure therapy devices, chin straps, and others. Based on end-user segmentation, the market can be categorized into hospitals, sleep therapy clinics, and home care.

Geographically, the anti-snoring device market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key Players Covered:

Some of the major companies that are present in the Anti-Snoring Device market are ResMed, Koninklijke Philips N.V, Fisher and Paykel Healthcare Limited, Apnea Sciences, ASF Medical GmbH, Sleeping Well LLC, Somnomed Ltd., others prominent players

Key Insights:

• Key Industry Developments – Merger, Acquisitions, and Partnerships


• Key Product Launches


• Key Industry Trends


• Epidemiology of Major Sleep Disorder, Key Regions


• COVID-19 Impact on Anti-Snoring Device Market

Regional Analysis:

Based on region segmentation, the anti-snoring device market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to dominate the market in 2020 and is estimated to retain its dominating position during the forecast period. Factors such as higher availability of the advanced anti-snoring device, larger awareness regarding airway blockage implications, and higher disposable income to treat disorders such as snoring, among others, are estimated to drive the market in the coming years. In Europe, the market is stirred by factors such as higher adoption of anti-snoring devices, active publishing of healthcare guidelines for snoring management by organizations, and government initiative to increase awareness regarding snoring management.

The market growth in the Asia Pacific is supplemented by increasing disposable incomes and rising geriatric populations in countries such as India, Japan, and China. The market in Latin America and Middle East countries, and Africa is expected to grow slower than other regions owed to limited penetration of advanced medical devices.

Segmentation

Anti-Snoring Device Market Industry Developments

• In December 2020, Signifier, a British start-up biotechnology company are preparing to launch its novel anti-snoring device in the U.S market. The company is aiming to reach a target funding of US$ 100 Mn for the same.


• In April 2019, Zyppah received U.S FDA approval to market its oral anti snoring device in the U.S. The company received an over-the counter device approval for marketing of the device.